EMA organises public meeting on COVID-19 vaccines

The European Medicines Agency (EMA) has organised a public meeting on 11 December 2020 to inform European citizens about the EU regulatory processes for the approval of COVID-19 vaccines.

The EMA will also discuss their role in the development, evaluation, approval and safety monitoring of the vaccines.

The meeting will be an opportunity for the public and stakeholders to share their needs, expectations and concerns which the EMA and the European medicines regulatory network can consider in their decision-making processes.

For more information on how to join and contribute to the meeting, please read the press release.

Tagged with

Published on 23. November 2020 in News, News EU, Press Release